Explore This Treatment Program

About the Program

The Pediatric Transplant Program at MassGeneral Hospital for Children is a major referral center for organ transplants for children. Our surgeons and transplant teams are at the forefront of pediatric organ transplantation and work to ensure optimal treatment before, during and after transplant. Our multidisciplinary approach ensures the optimal care for our patients and gives them the benefit of more than 40 years of experience in transplantation at Massachusetts General Hospital.

Our program is uniquely equipped to facilitate parent-to-child donation, with adjacent operating space and adult and pediatric operating teams.

As part of the Massachusetts General Hospital Transplant Center, we are also uniquely suited to provide seamless continuity of care from pediatric through adolescent and adult care.

The Mass General Transplant Center offers leading-edge consultative services, treatment and surgical interventions to patients with a broad spectrum of diseases requiring heart, lung, liver, kidney, pancreas, islet, hematopoietic stem cell and multiple organ transplants. The pediatric program currently provides several of these and will be expanding in the future.

An innovator in the transplant field for nearly three decades, the Mass General Transplant Center has developed life-saving techniques that have revolutionized transplant medicine for patients around the globe. Major transplant milestones include:

  • World’s first successful tolerance induction in mismatched renal recipients 
  • World’s first clinical use of a monoclonal antibody used in the prevention and treatment of graft rejection
  • First regional lung transplant program for Medicare
  • New England’s first live donor lung transplant program

Surgeons at Mass General performed New England’s first successful:

  • Pancreas transplant
  • Liver transplant
  • Small bowel transplant
  • Combined liver/heart transplant

Standard-Setting Research and Care

As part of the largest hospital-based research program in the United States, our research focuses on developing new breakthrough treatments and techniques that offer excellent clinical outcomes for patients, including:

  • Innovative treatments of immunosuppression, to reduce the likelihood of acute organ rejection
  • Novel approaches to avoid immunosuppression through tolerance induction, allowing kidney transplant recipients to live drug-free after their transplantations
  • Pioneering and effective approaches to the prevention of infectious disease in transplantation

The quality of our patient care is also enhanced by:

  • Our commitment to developing leading-edge technology
  • The development of minimally invasive transplantation innovations: The Transplant Center is one of the few in the region to offer transplantation of healthy islet cells into type I diabetes patients who are not candidates for a full pancreas transplant
  • Our dedication to identifying and utilizing available organs

Emphasis on Teaching and Research

As a Harvard Medical School teaching institution, we are training the next generations of transplant specialists in all areas of medicine and surgery, bringing fresh perspectives to the care of our patients and improving the care of transplant recipients worldwide. Our unique portfolio of basic and clinical research, education and clinical expertise benefits each patient receiving care at the Transplant Center.